BiochemProbe — Life Science Research Reagents

SMARCA-BD ligand 1 for Protac free base

SMARCA-BD ligand 1 for PROTAC is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC[1].

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

SMARCA-BD ligand 1 for Protac structure

CAS No.: 1997319-92-2

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
500 mg USD 250.00 BP-02194-500mg In stock Get quote
1 g USD 380.00 BP-02194-1g In stock Get quote
2 g USD 610.00 BP-02194-2g In stock Get quote
3 g USD 720.00 BP-02194-3g In stock Get quote
5 g USD 980.00 BP-02194-5g In stock Get quote
10 g USD 1,560.00 BP-02194-10g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

SMARCA-BD ligand 1 for PROTAC is a compound that binds to the BAF ATPase subunits SMARCA2, and used for degrading SMARCA2, based on PROTAC[1].

Biological activity

In Vitro PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

Identifiers

SMILES
OC1=CC=CC=C1C2=NN=C(N)C(N3CCNCC3)=C2
InChIKey
SZKHGLTYXIDOFH-UHFFFAOYSA-N

Specifications

MW (average)
271.3177
Formula
C14H17N5O
CAS No.
1997319-92-2
Physical state
Solid
Color
Light yellow to light brown
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 month;

Solubility

soluble in DMSO

References

[1]. Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15(7):672-680.

Same research area

Search Cancer